VA Cancer Clinical Trials as a Strategy for Increasing Accrual of Racial and Ethnic Underrepresented GroupsSeptember 12, 2024Oncology
Posterior Reversible Encephalopathy Syndrome (PRES) Following Bevacizumab and Atezolizumab Therapy in Hepatocellular Carcinoma (HCC)September 12, 2024Oncology
CDK7 Inhibition in Patient-Derived Organoid Modeling of Biliary Tract CancersSeptember 12, 2024Oncology
The OCTAGON Project: A Novel VA-Based Telehealth Intervention for Oral Chemotherapy MonitoringSeptember 12, 2024Prostate CancerOncologyLung CancerLymphoma & Plasma Cell Disorders
Carboplatin as a Radiosensitizing Agent in Locally Advanced Head and Neck Cancer: Friendly to an Older Veteran PopulationSeptember 12, 2024OncologyHead & Neck/Thyroid Cancers
How to Make Keeping Up With the Drugs as Easy as Keeping Up With the Kardashians: Implementing a Local Oncology Drug Review CommitteeSeptember 12, 2024Oncology
PHASER Testing Initiative for Patients Newly Diagnosed With a GI MalignancySeptember 12, 2024OncologyColon and Rectal
Barriers from Detection to Treatment in Lung Cancer: A Single Veteran Affair Institution ReviewSeptember 12, 2024OncologyLung Cancer
Cholangioblastic Intrahepatic Cholangiocarcinoma: A Rare Case of an Inhibin-Positive Variant Mimicking Neuroendocrine TumorsSeptember 12, 2024Oncology
Variation in Cardiovascular Risk Assessment Status in Patients Receiving Oral Anti-Cancer Therapies: A Focus on Equity throughout VISN (Veteran Integrated Service Network) 12September 11, 2024Oncology
Implementing a Prospective Surveillance Physical Therapy Program for Those Affected by CancerSeptember 11, 2024Prostate CancerOncology
Developing a Cancer Rehabilitation Program—Improving Access to Ancillary Services to Mitigate the Impact of Cancer and its Treatments for Veterans Diagnosed With CancerSeptember 11, 2024Oncology
Whole Health Oncology—Just Do It: Making Whole Person Cancer Care Routine and Regular at the Dayton VA Medical Center (DVAMC)September 11, 2024Prostate CancerOncologyBreast Cancer
